Morning research

StockRadar.ru

Gapping down

In reaction to disappointing earnings/guidance:

XGTI -18.2%,MTSI -13.1%,SITO -8.4%,SRAX -7.4%,JASO -7.2%,FTFT -6.7%, (anticipate that we will report the following significant changes in the results of operations from the same period of the last fiscal year), GTXI-6.4%, YRD-5.1%, SBH-4.5%, PRKR-4%, TGT -4%,DGLY -3.2%,EVOK -3.2%,NXTD -1.4%,AMRK -1.3%,LTBR -0.9%

Other news:

ACOR -31% (provides update on Tozadenant development program)
ACHN -7.9% (reports preliminary proof-of-concept results from group 1 of its ongoing Phase 2, open-label, 14-day study of ACH-4471 for patients with C3 glomerulopathy; Achillion Pharma announces that Johnson & Johnson (JNJ) intends to offer for sale in an underwritten public offering 18,367,346 shares of Common Stock)
PSDO -3.6% (announces commencement of a proposed secondary public offering of 8 mln shares of common stock by certain funds affiliated with Apollo Global Management),G -3.4% (announces underwritten public offering of 10 mln common shares by certain shareholders)
OMAM -2.9% (launches public offering of 6,039,630 of its ordinary shares by Old Mutual )
SAGE -2% (prices offering of 3,529,411 shares of common stock at $85.00 per share)
SYF -1.4% (after Berkshire Hathaway disclosed increased stake)
IBM -1.1% (Berkshire Hathaway discloses lowered stake)

Analyst comments:

SNAP -1.4% (downgraded to Mkt Perform from Mkt Outperform at JMP Securities)
FTI -1.3% (downgraded to Reduce from Hold at HSBC Securities)
THS -1.2% (downgraded to Market Perform from Outperform at BMO Capital Markets)

Gapping up

In reaction to strong earnings/guidance:

SORL +48.6%,APHB +22.1%,NVCN +19%,SYNC +13%,MCEP +11.4%,WPRT +10%,CARG +9.8%,MLSS +7%,RLOG +5%,APTO +4.6%,IMMY +4.3%,BZH +4.1%,JRJC +3.8%,MTOR +3.4%,PLCE +3.4%,YY +2.6%,AMRS +2.5%,AKER +2.5%,PYDS +2.2%,CDTI +2%,CRME +1.4%

M&A news:

SNCR +3.5% (has completed the sale of its wholly owned subsidiary Intralinks Holdings to an investment fund affiliated with Siris Capital Group)
BCEI +1.1% (to be acquired by SandRidge Energy (SD) for $36.00/share in cash & stock)

Other news:

TRXC +5.9% (modestly rebounding)
AAOI +4.3% (Director disclosed the purchase of 22.4K shares)
LRCX +1.7% ( authorizes $2 billion share repurchase and 11% increase of quarterly dividend to $0.50 per share)
AVEO +1.3% (AVEO Oncology and EUSA Pharma announced the first commercial launch of FOTIVDA in Germany)
ALKS +1% (Alkermes' VIVITROL featured in The Lancet)

Analyst comments:

Report Page